Home Excelencia Severo Ochoa
Collaborations
  • Mariona Arbonés, Centro de Regulación Genómica, Barcelona

  • Angel Luis Armesilla, Division of Cardiology. The University of Manchester.

  • Montserrat Batlle, Eulalia Roig and José Luis Pomar, Hospital Clinic Barcelona.

  • Luis Jesús Borreguero, Centro Nacional de Investigaciones Cardiovasculares, Madrid.

  • Miguel Campanero, Instituto de Investigaciones Biológicas, Madrid.

  • Eva Cano, Centro Nacional de Investigaciones Cardiovasculares. Madrid.

  • Martha Cyert, Department of Biological Sciences. Stanford University.

  • Javier Díez, CIMA, Pamplona.

  • Manuel Fresno and Miguel Ángel Iñiguez, Centro de Biología Molecular “Severo Ochoa”. Madrid.

  • David García Dorado, Institut de Recerca Vall d’Hebron. Barcelona.

  • Katia Georgopoulos, Massachussets General Hospital, Boston.

  • Rosario González Muñiz, Instituto de Química Médica CSIC, Madrid.

  • Jesper Haeggström. Department of Medical Biochemistry and Biophysics. Karolinska Institutet. Stockholm.

  • Cristina López Rodríguez and José Aramburu, Universidad Pompeu Fabra, Barcelona.

  • Susana de la Luna, Genes and Disease Program, Centre de Regulació Genómica . Parc de Recerca Biomèdica de Barcelona.

  • Francisco Martín and Mario Delgado, IPB “López Neyra”, Granada.

  • Jorge Martín Pérez, Instituto de Investigaciones Biológicas, Madrid.

  • Takashi Minami, The Research Center for Advanced Science and Technology. The University of Tokyo. Tokyo.

  • Marta Nieto, Centro Nacional de Biotecnología. Madrid.

  • Julio Osende , Hospital Gregorio Marañón. Madrid.

  • José Luis de la Pompa, Centro Nacional de Investigaciones Cardiovasculares, Madrid.

  • Antonio Rodríguez, Universidad Autónoma de Madrid.

  • Mercedes Salaices, Universidad Autónoma de Madrid.

  • Francisco Sánchez-Madrid, Departamento de Inmunología, Hospital Universitario de la Princesa, Madrid y Centro Nacional de Investigaciones Cardiovasculares. Madrid.

  • David Sancho, Centro Nacional de Investigaciones Cardiovasculares, Madrid.

  • Jesús Vázquez, Centro de Biología Molecular “Severo Ochoa” . Madrid.

  • Timothy Warner and David Bishop-Bailey, Dept. of Cardiac, Vascular & Inflammation Research. Queen Mary & Westfield College. University Of London.

  • Leon de Windt, Utrech University.

Juan Miguel Redondo
  • Juan Miguel Redondo Moya
  • Department Director
  • Ext.1150

Dr. Redondo studied for his degree in (Biochemistry, 1982) and his PhD (1987) at the Universidad Autónoma de Madrid. During his doctoral and postdoctoral training he worked in the field of Immunology, mostly on the transcriptional activation and regulation of T lymphocytes and the mechanisms of T cell differentiation. This work was carried out at the Centro de Biología Molecular Severo Ochoa (CBMSO), the Hospital de la Princesa de Madrid, Harvard Medical School, and Duke Medical Center. Dr. Redondo started his own laboratory in 1995, initially at the CBMSO (CSIC/UAM), and his area of interest expanded to the transcriptional regulation of endothelial activation, angiogenesis and inflammation. Much of his work centers on the regulation and function of the calcineurin/NFAT signaling pathway. Apart from its implication in the processes mentioned above, this pathway plays important roles in chronic inflammatory diseases, cardiac hypertrophy and ischemic retinopathy. All of these physiological and pathophysiological processes are the focus of research in Dr. Redondo’s group. Through an agreement with the CSIC, of which he is a Profesor de Investigación, in November 2001 Dr. Redondo joined the CNIC, where he is a Senior Researcher in the Department of Vascular Biology and Inflammation